# EDGAR Filing Document

**Accession Number:** 0000818479
**File Stem:** 0000818479-25-000120
**Filing Date:** 2025-7
**Character Count:** 10687
**Document Hash:** 6c964be220a45dad035727672ed76024
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000818479-25-000120.hdr.sgml**: 20250715

**ACCESSION NUMBER**: 0000818479-25-000120

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250711

**FILED AS OF DATE**: 20250715

**DATE AS OF CHANGE**: 20250715

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Campion Simon D
- **CENTRAL INDEX KEY:** 0001751919

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-16211
- **FILM NUMBER:** 251125182

**MAIL ADDRESS:**
- **STREET 1:** DENTSPLY SIRONA INC
- **STREET 2:** 13320 BALLANTYNE CORPORATE PLACE
- **CITY:** CHARLOTTE
- **STATE:** NC
- **ZIP:** 28277
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** DENTSPLY SIRONA Inc.
- **CENTRAL INDEX KEY:** 0000818479
- **STANDARD INDUSTRIAL CLASSIFICATION:** DENTAL EQUIPMENT & SUPPLIES [3843]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 391434669
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 13320 BALLANTYNE CORPORATE PLACE
- **CITY:** CHARLOTTE
- **STATE:** NC
- **ZIP:** 28277-3607
- **BUSINESS PHONE:** 844-546-3722

**MAIL ADDRESS:**
- **STREET 1:** 13320 BALLANTYNE CORPORATE PLACE
- **CITY:** CHARLOTTE
- **STATE:** NC
- **ZIP:** 28277-3607

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DENTSPLY INTERNATIONAL INC /DE/
- **DATE OF NAME CHANGE:** 19930630

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GENDEX CORP
- **DATE OF NAME CHANGE:** 19920703

## Ex-24

```

                        DENTSPLY SIRONA Inc.
Limited Power of Attorney for Section 16 Reporting Obligations

Know all by these presents that the undersigned hereby
constitutes and appoints each of Richard Rosenzweig, Jessica
Causey, and Lindi Barton-Brobst, or any of them acting singly and
with full power of substitution, the undersigned's true and
lawful attorney-in-fact to:

       1. Execute for and on behalf of the undersigned, in the
undersigned's capacity as an officer or director or both of
DENTSPLY SIRONA Inc. (the "Company"), Forms 3, 4 and 5 (and any
amendments thereto) in accordance with Section 16(a) of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"),
and the rules thereunder;

       2. To perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete and
execute any such Forms 3, 4 or 5, complete and execute any
amendments thereto, and timely file such forms with the U.S.
Securities and Exchange Commission (the "SEC") and any securities
exchange or similar authority, including without limitation the
filing of a Form ID or any other documents necessary or
appropriate to enable the undersigned to file the Forms 3, 4 and
5 electronically with the SEC;

       3. Seek or obtain, as the undersigned's representative and
on the undersigned's behalf, information on transactions in the
Company's securities from any third party, including brokers,
employee benefit plan administrators and trustees, and the
undersigned hereby authorizes any such person to release any such
information to each of the undersigned's attorneys-in-fact
appointed by this Limited Power of Attorney and approves and
ratifies any such release of information;

       4. Take any other action in connection with the foregoing
which, in the opinion of such attorney-in-fact, may be of benefit
to, in the best interest of, or legally required by or for, the
undersigned, it being understood that the documents executed by
such attorney-in-fact on behalf of the undersigned pursuant to
this Limited Power of Attorney shall be in such form and shall
contain such information and disclosure as such attorney-in-fact
may approve in such attorney-in-fact's discretion.

	The undersigned hereby grants to each such attorney-in-fact
full power and authority to do and perform any and every act and
thing whatsoever required, necessary or proper to be done in the
exercise of any of the rights and powers herein granted, as fully
to all intents and purposes as the undersigned might or could do
if personally present, with full power of substitution or
revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to be done by virtue of
this Limited Power of Attorney and the rights and powers herein
granted.

           The undersigned acknowledges that the foregoing
attorneys-in-fact, in serving in such capacity at the request and
on the behalf of the undersigned, are not assuming, nor is the
Company assuming, any of the undersigned's responsibilities to
comply with, or any liability for the failure to comply with, any
provision of Section 16 of the Exchange Act.

           This Limited Power of Attorney shall remain in full
force and effect until the undersigned is no longer required to
file Forms 3, 4 or 5 with respect to the undersigned's holdings
of and transactions in securities issued by the Company, unless
earlier revoked by the undersigned in a signed writing delivered
to the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has executed this Limited
Power of Attorney as of this 22nd day of May 2025.

Signed and acknowledged:

/s/
Simon D. Campion

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Campion Simon D<br><sub>(Last) (First) (Middle)</sub><br>C/O DENTSPLY SIRONA INC<br>13320-B BALLANTYNE CORPORATE PLACE<br><sub>(Street)</sub><br>CHARLOTTE, NC 28277<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-07-11 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_President, CEO & Member of BOD_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>DENTSPLY SIRONA Inc. [ XRAY ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-07-11 |  | A |  | 1260.911<sup>(1)</sup> | A | $0 | 272403.9801<sup>(2)(3)</sup> | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Phantom Stock (Supplemental Executive Retirement Plan) SERP | <sup>(4)</sup> | 2025-07-11 |  | A |  | 131.3974<sup>(5)</sup> |  | <sup>(4)</sup> | <sup>(4)</sup> | Common Stock | 131.3974 | $16.20 | 13353.196 | D |  |

---

### Footnotes:

(1) Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.

(2) Includes 370 shares acquired between January 1st - June 30, 2025 under the Dentsply Sirona Employee Stock Purchase Plan.

(3) Includes 1,178.392 shares acquired through dividend reinvestment on 7/10/2025.

(4) Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment.

(5) Comprised of phantom stock acquired as a result of accrued dividends.

**Remarks:**
Exhibit 24 - Power of Attorney

**Signature:** /s/ Jessica Causey, Attorney-In-Fact for Simon D. Campion  
**Date:** 2025-07-15

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**